Atopic Dermatitis (Infantile Eczema)
Chronic Relapsing Pruritic Inflammatory Skin Disease
Primary risk age: Infants starting at 2 to 6 months through childhood and adolescence.
- Urgency
- Mild
- Typical age
- Infants starting at 2 to 6 months through childhood and adolescence.
- Body system
- Dermatological System
Typical course: This is a chronic, relapsing condition characterized by periodic flare-ups and periods of remission over several years.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Chronic Relapsing Pruritic Inflammatory Skin Disease
Pathophysiology (Development Path)
Loss of function mutations in the filaggrin gene impair the skin's barrier function, leading to increased transepidermal water loss and structural cracking. This allows allergens and pathogens to penetrate the skin easily, triggering an inflammatory response. The resulting intense pruritus leads to scratching, which damages the barrier further and drives a chronic itch-scratch cycle.
Primary Causes & Etiology
A combination of genetic mutations altering epidermal proteins (such as filaggrin) and immune dysregulation (Th2-mediated), triggered by environmental allergens, soaps, or climate shifts.
2. Symptom Continuum
- Early Onset Signs
Erythematous, dry, scaling plaques on the cheeks, scalp, and extensor surfaces of the limbs in infants, accompanied by visible scratching or rubbing.
- Progressive Phase
Intense pruritus, lichenification (thickening of the skin with accentuated skin lines) in the flexural folds (such as the antecubital and popliteal fossae), and dry, flaky skin across the trunk.
- Severe Indicators
Widespread eczematous flares covering large areas of the body, painful cracking with serous exudate (weeping), and secondary bacterial infections marked by honey-colored crusts.
3. Clinical Verification
Clinical diagnosis based on the distribution of skin lesions, a history of intense itching, and a personal or family history of atopic conditions like asthma or allergic rhinitis.
4. Care & Elements Plan
Primary Care Treatment Plan
Restore the epidermal barrier, maintain skin hydration, and suppress active inflammation during flares using targeted topical anti-inflammatory agents.
Home Support Elements
Lukewarm baths lasting 5-10 minutes using mild, soap-free cleansers, followed immediately by the application of thick, bland emollients. Use cotton clothing and avoid known triggers like harsh laundry detergents.
Generic Active Ingredients (No Brands)
- Hydrocortisone ointment (low-potency topical corticosteroid active ingredient for facial lesions)
- Triamcinolone acetonide (medium-potency topical steroid for thick trunk/limb plaques)
- Mupirocin (topical antibiotic if secondary bacterial infection is present).
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Consult a healthcare provider if the skin shows signs of a secondary bacterial infection (such as pustules or honey-colored crusts) or if the itching disrupts the child's sleep.
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
Regular use of emollients from birth may help protect the skin barrier in infants with a strong family history of atopic disease.
Immunization Context
No specific immunizations are associated with this skin condition. Avoid live viral vaccines during severe, generalized eczematous erythroderma flares.
7. Timelines & Outlook
Active Timeline
This is a chronic, relapsing condition characterized by periodic flare-ups and periods of remission over several years.
Expected Prognosis
Good. Many children see significant improvement or complete resolution of symptoms as they approach adolescence, though dry skin may persist into adulthood.
Potential Untreated Complications
Secondary bacterial infections (typically Staphylococcus aureus pyoderma), eczema herpeticum (widespread viral infection from Herpes Simplex Virus), sleep disruption, and psychosocial impacts.
More in Atopic & Hypersensitivity Epidermal Barriers
Mild Erythema Toxicum Neonatorum (ETN)
Benign Transient Neonatal Pustular Dermatosis
Neonates (Typically presents within 24 to 72 hours of birth; rare in premature infants)
Mild Pityriasis Rosea
Benign Self-Limiting Post-Viral Exanthem
5 to 15 Years (Peak occurrence)
Mild Diaper Dermatitis (Diaper Rash)
Common irritant or fungal inflammation of the skin in the diaper area.
Infants and toddlers in diapers, most common at 9–12 months.